KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 101 filers reported holding KARUNA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $503 | -52.8% | 2,320 | -60.5% | 0.04% | -66.4% |
| Q1 2023 | $1,066 | +391.2% | 5,870 | +431.2% | 0.11% | +289.7% |
| Q4 2022 | $217 | -100.0% | 1,105 | -74.0% | 0.03% | -66.7% |
| Q3 2022 | $955,000 | +105.4% | 4,248 | +4.1% | 0.09% | +93.3% |
| Q2 2021 | $465,000 | -12.6% | 4,081 | -14.5% | 0.04% | -26.2% |
| Q2 2020 | $532,000 | +50.7% | 4,775 | +1.9% | 0.06% | +79.4% |
| Q4 2019 | $353,000 | – | 4,686 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |